Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02684032
Title A Study To Assess The Tolerability And Clinical Activity Of Gedatolisib In Combination With Palbociclib/Letrozole Or Palbociclib/Fulvestrant In Women With Metastatic Breast Cancer
Recruitment Active, not recruiting
Gender female
Phase Phase I
Variant Requirements Yes
Sponsors Pfizer
Indications

Her2-receptor negative breast cancer

Therapies

Letrozole

Fulvestrant

Gedatolisib + Palbociclib

Age Groups: adult
Covered Countries USA

Additional content available in CKB BOOST